Form 4: Encompass Health Director Kevin J. O'Connor Reports Acquisition of Additional Shares Through Dividend Reinvestment

Director Kevin J. O'Connor acquired 13 shares of Encompass Health Corp through dividend reinvestment on July 15, 2024.

Summary

• Kevin J. O'Connor, a director of Encompass Health Corp, reported the acquisition of 13 shares of common stock on July 15, 2024.
• The acquisition was a result of dividend payments on outstanding restricted stock units (RSUs).
• Encompass Health paid a dividend of $0.15 per share on its common stock on July 15, 2024.
• The closing price of Encompass Health's common stock on the dividend payment date was $85.49.
• Following the transaction, O'Connor directly owns 8,401 shares of Encompass Health common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine transaction (dividend reinvestment). It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

This filing is a routine disclosure related to insider transactions, specifically the acquisition of shares through dividend reinvestment, which is a common practice for executives and directors holding company stock or RSUs.

Stakeholder Impact

• The transaction has a negligible impact on stakeholders as it involves a small number of shares acquired through dividend reinvestment.

Key Dates